首页> 外文OA文献 >Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

【2h】

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

机译：使用血清HER2水平和循环肿瘤细胞同时测定原发性肿瘤HER2阴性或HER2状态未知的复发性乳腺癌患者的HER2状态

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tanja Fehm; Sven Becker; Silke Duerr-Stoerzer; Karl Sotlar; Volkmar Mueller; Diethelm Wallwiener; Nancy Lane; Erich Solomayer; Jonathan Uhr;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status [J] . Tanja Fehm, Sven Becker, Silke Duerr-Stoerzer, Breast Cancer Research . 2007,第5期

机译：使用血清HER2水平和循环肿瘤细胞确定原发性肿瘤HER2阴性或HER2状态未知的复发性乳腺癌患者的HER2状态
2. SUCCESSFUL USE OF HER2 TARGETED AGENTS IN PATIENTS WITH HEAVILY PRETREATED HER2-NEGATIVE METASTATIC BREAST CANCER PRESENTING WITH ELEVATED SERUM LEVELS OF THE HER2 EXTRACELLULAR DOMAIN AND/OR HER2 OVEREXPRESSING CIRCULATING TUMOR CELLS [J] . Kurbacher Christian Martin, Quade Annegret, Kunstmann Gerhard, The Breast : . 2015,第Suppla3期

机译：成功使用HER2阴性的转移性乳腺癌较重治疗的HER2阴性乳腺癌患者，如果其血清水平升高且HER2胞外域水平升高和/或HER2过度表达循环肿瘤细胞，则可成功使用HER2靶向剂
3. SUCCESSFUL USE OF HER2 TARGETED AGENTS IN PATIENTS WITH HEAVILY PRETREATED HER2-NEGATIVE METASTATIC BREAST CANCER PRESENTING WITH ELEVATED SERUM LEVELS OF THE HER2 EXTRACELLULAR DOMAIN AND/OR HER2 OVEREXPRESSING CIRCULATING TUMOR CELLS [J] . Kurbacher Christian Martin, Quade Annegret, Kunstmann Gerhard, The Breast : . 2015,第Suppla3期

机译：在患有大量预处理的Her2阴性转移性乳腺癌患者患者中，患有Her2细胞外结构域的血清水平和/或HER2过表达循环肿瘤细胞患者的患者
4. Determination of HER2 Amplification Status in Breast Cancer Cells Using Raman Spectroscopy [C] . Xiaohong Bi, Brent Rexer, Carlos L Arteaga, Biomedical vibrational spectroscopy IV: Advances in research and industry . 2010

机译：拉曼光谱法测定乳腺癌细胞中HER2的扩增状态
5. HER2Delta16: a tumor-specific oncogene that drives tumorigenesis and trastuzumab resistance in HER2+ breast cancer. [D] . Huynh, Felicia C. 2015

机译：HER2Delta16：一种肿瘤特异性癌基因，可驱动HER2 +乳腺癌的肿瘤发生和曲妥珠单抗。
6. Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status [O] . Tanja Fehm, Sven Becker, Silke Duerr-Stoerzer, 2007

机译：使用血清HER2水平和循环肿瘤细胞确定原发性肿瘤HER2阴性或HER2状态未知的复发性乳腺癌患者的HER2状态
7. Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status [O] . Fehm, Tanja, Becker, Sven, Duerr-Stoerzer, Silke, 2007

机译：使用血清HER2水平和循环肿瘤细胞同时测定原发性肿瘤HER2阴性或HER2状态未知的复发性乳腺癌患者的HER2状态

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

著录项

引文网络

相似文献

相关主题

期刊订阅